Paper41131990
Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera.
Sato K and 12 others. Microbiol Immunol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera. Papers, record 41131990. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41131990
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Influenza Vaccines | Major topic |
| Influenza, Human | Major topic |
| Hemagglutinin Glycoproteins, Influenza Virus | Major topic |
| Immunogenicity, Vaccine | Major topic |
| Animals | |
| Antibodies, Viral | |
| Mice | |
| Humans | |
| Mice, Inbred BALB C | |
| Antibodies, Neutralizing | |
| Female | |
| Seasons | |
| Vaccine Efficacy | |
| Orthomyxoviridae Infections |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
This study was partially supported by a grant-in-aid (Numbers 22fk0108649j0501 and 24mk0121291j0301) from the Japan Agency for Medical Research and Development and the Grants-in-Aid for Scientific Research (JSPS KAKENHI grant numbers 20K04826 and 24K01043). | PubMed |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38030271 | Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation. | Jpn J Infect Dis | 2024 | https://conductscience.org/library/papers/38030271 | PubMed |
| 2 | 29356318 | Standardisation of inactivated influenza vaccines-Learning from history. | Influenza Other Respir Viruses | 2018 | https://conductscience.org/library/papers/29356318 | PubMed |
| 3 | 21911027 | Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice. | Vaccine | 2011 | https://conductscience.org/library/papers/21911027 | PubMed |
| 4 | 39516286 | Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection. | Sci Rep | 2024 | https://conductscience.org/library/papers/39516286 | PubMed |
| 5 | 10763706 | A role for MHC class II antigen processing in B cell development. | Int Rev Immunol | 2000 | https://conductscience.org/library/papers/10763706 | PubMed |
| 6 | 18255203 | Host genetic factors that control immune responses to retrovirus infections. | Vaccine | 2008 | https://conductscience.org/library/papers/18255203 | PubMed |
| 7 | 31191534 | Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus. | Front Immunol | 2019 | https://conductscience.org/library/papers/31191534 | PubMed |
| 8 | 38729197 | Probable extinction of influenza B/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases. | Lancet Microbe | 2024 | https://conductscience.org/library/papers/38729197 | PubMed |
| 9 | 9619772 | Genetic vaccines: strategies for optimization. | Pharm Res | 1998 | https://conductscience.org/library/papers/9619772 | PubMed |
| 10 | 30623129 | Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine. | Heliyon | 2019 | https://conductscience.org/library/papers/30623129 | PubMed |
| 11 | 38276675 | Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38276675 | PubMed |
| 12 | 17084490 | Dengue tetravalent DNA vaccine increases its immunogenicity in mice when mixed with a dengue type 2 subunit vaccine or an inactivated Japanese encephalitis vaccine. | Vaccine | 2007 | https://conductscience.org/library/papers/17084490 | PubMed |
| 13 | 25766602 | Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain. | Jpn J Infect Dis | 2015 | https://conductscience.org/library/papers/25766602 | PubMed |
| 14 | 35848945 | An In Vitro Microneutralization Assay for Influenza Virus Serology. | Curr Protoc | 2022 | https://conductscience.org/library/papers/35848945 | PubMed |
| 15 | 1694041 | T cell reactivity to MHC molecules: immunity versus tolerance. | Science | 1990 | https://conductscience.org/library/papers/1694041 | PubMed |
| 16 | 34358203 | Animal Models Utilized for the Development of Influenza Virus Vaccines. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358203 | PubMed |
| 17 | 4021180 | Potency test of hepatitis B vaccines by the parallel line assay method in mice. | Jpn J Med Sci Biol | 1985 | https://conductscience.org/library/papers/4021180 | PubMed |
| 18 | 22135019 | Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. | Vet Pathol | 2012 | https://conductscience.org/library/papers/22135019 | PubMed |
| 19 | 29081496 | The evolution of seasonal influenza viruses. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29081496 | PubMed |
| 20 | 17056527 | Enhanced IgA class switching in marginal zone and B1 B cells relative to follicular/B2 B cells. | J Immunol | 2006 | https://conductscience.org/library/papers/17056527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41131990
GET https://conductscience.org/api/papers/v1/41131990/references?page=2